COVID-19Regulatory

Clinical trials on coronavirus drugs may take only months, researcher says

March 28, 2020 / By Gabe Gutierrez and Dennis Romero

An infectious disease specialist leading three clinical trials into treatments for coronavirus said he expects the work to go quickly.

“If everything goes according to plan, I am talking months, not years,” for completion of the trials, Dr. Timothy Schacker, vice dean for research at the University of Minnesota’s medical school, told NBC News.

Clinical trials often can take years, Schacker said, but these may take less time in part because the process of finding patients to participate is happening quickly.

A high amount of interest in coronavirus treatment research is helping in recruiting participants, Schacker said. In addition, researchers are using the internet and social media to get the word out.

His teams’ trials are trying to answer three questions, he said: Can you prevent a person from getting infected? Once a person has the coronavirus, can you prevent them from getting more sick? And, lastly, once a person is sick, is there a treatment to fight the infection?

READ THE REST HERE

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button